CPO
TCRT icon

Cerity Partners OCIO’s Alaunos Therapeutics TCRT Stock Holding History

Cerity Partners OCIO’s Portfolio TCRT Stock Details TCRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$8K Hold
87
– – ﹤0.01% 426
2022
Q3 		$23K Hold
87
– – ﹤0.01% 413
2022
Q2 		$16K Hold
87
– – ﹤0.01% 418
2022
Q1 		$8K Hold
87
– – ﹤0.01% 420
2021
Q4 		$14K Hold
87
– – ﹤0.01% 417
2021
Q3 		$24K Buy
+87
New +$26.6K ﹤0.01% 407

Other funds holding TCRT

DCM
Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return
MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Addison Capital Conshohocken, Pennsylvania $562M AUM 18.57% 1-Year Est. Return
SGCA
Steel Grove Capital Advisors Memphis, Tennessee $949M AUM 23.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Cerity Partners OCIO's TCRT Position: Q4 2022 in Review

Cerity Partners OCIO held its Alaunos Therapeutics (TCRT) position steady in Q4 2022 at 87 shares worth $8K. The position accounts for ﹤0.01% of the portfolio, ranked #426.

Cerity Partners OCIO first reported a position in TCRT in Q3 2021 and has held it in 6 quarters since. The position peaked at $24K in Q3 2021. 122 funds tracked by Wall St. Rank hold TCRT as of Q4 2022.

  • Cerity Partners OCIO held 87 shares of Alaunos Therapeutics worth $8K as of Q4 2022.
  • Cerity Partners OCIO left its Alaunos Therapeutics share count unchanged in Q4 2022.
  • Alaunos Therapeutics made up ﹤0.01% of Cerity Partners OCIO's portfolio in Q4 2022, its #426 holding.
  • Cerity Partners OCIO first reported a position in Alaunos Therapeutics in Q3 2021 and has held it in 6 quarters since.
  • Cerity Partners OCIO's Alaunos Therapeutics position peaked at $24K in Q3 2021.
  • 122 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q4 2022.

Based on Cerity Partners OCIO's 13F filing for Q4 2022, filed 2 Feb 2023.